Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273961595> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2273961595 endingPage "3552" @default.
- W2273961595 startingPage "3545" @default.
- W2273961595 abstract "We conducted a phase I and pharmacokinetic study of docetaxel in combination with irinotecan to determine the dose-limiting toxicity (DLT), the maximum-tolerated dose (MTD), and the dose at which at least 50% of the patients experienced a DLT during the first cycle, and to evaluate the safety and pharmacokinetic profiles in patients with advanced solid tumors.Patients with only one prior chemotherapy treatment (without taxanes or topoisomerase I inhibitors) for advanced disease were included in the study. Docetaxel was administered as a 1-hour IV infusion after premedication with corticosteroids followed immediately by irinotecan as a 90-minute IV infusion, every 3 weeks. No hematologic growth factors were allowed.Forty patients were entered through the following seven dose levels (docetaxel/irinotecan): 40/140 mg/m(2), 50/175 mg/m(2), 60/210 mg/m(2), 60/250 mg/m(2), 60/275 mg/m(2), 60/300 mg/m(2), and 70/250 mg/m(2). Two hundred cycles were administered. Two MTDs were determined, 70/250 mg/m(2) and 60/300 mg/m(2); the DLTs were febrile neutropenia and diarrhea. Neutropenia was the main hematologic toxicity, with 85% of patients experiencing grade 4 neutropenia. Grade 3/4 nonhematologic toxicities in patients included late diarrhea (7.5%), asthenia (15.0%), febrile neutropenia (22.5%), infection (7.5%), and nausea (5.0%). Pharmacokinetics of both docetaxel and irinotecan were not modified with the administration schedule of this study.The recommended dose of docetaxel in combination with irinotecan is 60/275 mg/m(2), respectively. At this dose level, the safety profile is manageable. The activity of this combination should be evaluated in phase II studies in different tumor types." @default.
- W2273961595 created "2016-06-24" @default.
- W2273961595 creator A5016060072 @default.
- W2273961595 creator A5032111284 @default.
- W2273961595 creator A5035737598 @default.
- W2273961595 creator A5041588416 @default.
- W2273961595 creator A5045845903 @default.
- W2273961595 creator A5068106161 @default.
- W2273961595 creator A5078902632 @default.
- W2273961595 creator A5082689339 @default.
- W2273961595 creator A5084017417 @default.
- W2273961595 creator A5085121407 @default.
- W2273961595 creator A5089377108 @default.
- W2273961595 date "2000-10-20" @default.
- W2273961595 modified "2023-10-18" @default.
- W2273961595 title "Phase I and Pharmacokinetic Study of Docetaxel and Irinotecan in Patients With Advanced Solid Tumors" @default.
- W2273961595 cites W1968785826 @default.
- W2273961595 cites W1978228326 @default.
- W2273961595 cites W2024980393 @default.
- W2273961595 cites W2041996138 @default.
- W2273961595 cites W2048079370 @default.
- W2273961595 cites W2050088084 @default.
- W2273961595 cites W2089570360 @default.
- W2273961595 cites W2311628233 @default.
- W2273961595 cites W2740368365 @default.
- W2273961595 doi "https://doi.org/10.1200/jco.2000.18.20.3545" @default.
- W2273961595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11032597" @default.
- W2273961595 hasPublicationYear "2000" @default.
- W2273961595 type Work @default.
- W2273961595 sameAs 2273961595 @default.
- W2273961595 citedByCount "37" @default.
- W2273961595 countsByYear W22739615952016 @default.
- W2273961595 countsByYear W22739615952018 @default.
- W2273961595 countsByYear W22739615952022 @default.
- W2273961595 crossrefType "journal-article" @default.
- W2273961595 hasAuthorship W2273961595A5016060072 @default.
- W2273961595 hasAuthorship W2273961595A5032111284 @default.
- W2273961595 hasAuthorship W2273961595A5035737598 @default.
- W2273961595 hasAuthorship W2273961595A5041588416 @default.
- W2273961595 hasAuthorship W2273961595A5045845903 @default.
- W2273961595 hasAuthorship W2273961595A5068106161 @default.
- W2273961595 hasAuthorship W2273961595A5078902632 @default.
- W2273961595 hasAuthorship W2273961595A5082689339 @default.
- W2273961595 hasAuthorship W2273961595A5084017417 @default.
- W2273961595 hasAuthorship W2273961595A5085121407 @default.
- W2273961595 hasAuthorship W2273961595A5089377108 @default.
- W2273961595 hasConcept C112705442 @default.
- W2273961595 hasConcept C121608353 @default.
- W2273961595 hasConcept C126322002 @default.
- W2273961595 hasConcept C141071460 @default.
- W2273961595 hasConcept C2776694085 @default.
- W2273961595 hasConcept C2777063308 @default.
- W2273961595 hasConcept C2778300832 @default.
- W2273961595 hasConcept C2778850193 @default.
- W2273961595 hasConcept C2780259306 @default.
- W2273961595 hasConcept C2781190966 @default.
- W2273961595 hasConcept C29730261 @default.
- W2273961595 hasConcept C526805850 @default.
- W2273961595 hasConcept C71924100 @default.
- W2273961595 hasConcept C90924648 @default.
- W2273961595 hasConcept C98274493 @default.
- W2273961595 hasConceptScore W2273961595C112705442 @default.
- W2273961595 hasConceptScore W2273961595C121608353 @default.
- W2273961595 hasConceptScore W2273961595C126322002 @default.
- W2273961595 hasConceptScore W2273961595C141071460 @default.
- W2273961595 hasConceptScore W2273961595C2776694085 @default.
- W2273961595 hasConceptScore W2273961595C2777063308 @default.
- W2273961595 hasConceptScore W2273961595C2778300832 @default.
- W2273961595 hasConceptScore W2273961595C2778850193 @default.
- W2273961595 hasConceptScore W2273961595C2780259306 @default.
- W2273961595 hasConceptScore W2273961595C2781190966 @default.
- W2273961595 hasConceptScore W2273961595C29730261 @default.
- W2273961595 hasConceptScore W2273961595C526805850 @default.
- W2273961595 hasConceptScore W2273961595C71924100 @default.
- W2273961595 hasConceptScore W2273961595C90924648 @default.
- W2273961595 hasConceptScore W2273961595C98274493 @default.
- W2273961595 hasIssue "20" @default.
- W2273961595 hasLocation W22739615951 @default.
- W2273961595 hasLocation W22739615952 @default.
- W2273961595 hasOpenAccess W2273961595 @default.
- W2273961595 hasPrimaryLocation W22739615951 @default.
- W2273961595 hasRelatedWork W1976626931 @default.
- W2273961595 hasRelatedWork W2010640916 @default.
- W2273961595 hasRelatedWork W2025501584 @default.
- W2273961595 hasRelatedWork W2031823642 @default.
- W2273961595 hasRelatedWork W2032467083 @default.
- W2273961595 hasRelatedWork W2080953759 @default.
- W2273961595 hasRelatedWork W2106964779 @default.
- W2273961595 hasRelatedWork W2154517246 @default.
- W2273961595 hasRelatedWork W2268437644 @default.
- W2273961595 hasRelatedWork W2273961595 @default.
- W2273961595 hasVolume "18" @default.
- W2273961595 isParatext "false" @default.
- W2273961595 isRetracted "false" @default.
- W2273961595 magId "2273961595" @default.
- W2273961595 workType "article" @default.